Ignite Creation Date:
2024-10-26 @ 3:42 PM
Last Modification Date:
2024-10-26 @ 3:42 PM
Study NCT ID:
NCT06642740
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
None
First Post:
2024-10-13
Brief Title:
Study on the Efficacy and Safety of Avatricopal in Patients With CLD Complicated With Thrombocytopenia
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Study on the Efficacy and Safety of Avatricopal in Patients With Chronic Liver Disease With Selective Invasive and Minimally Invasive Surgery Combined With Thrombocytopenia
Status:
ENROLLING_BY_INVITATION
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
In this study patients with chronic liver disease undergoing selective invasive and minimally invasive surgery combined with thrombocytopenia were enrolled After enrollment liver disease treatment was supplemented with avatripopal for 5 days Biochemical indexes of avatripopal were monitored during treatment and after withdrawal The proportion of patients with platelet count 50109L on the day of selective invasive and minimally invasive surgery was analyzed The incidence of adverse events was observed
Detailed Description:
This is a single-center single-arm prospective study Patients with chronic liver disease undergoing selective invasive and minimally invasive surgery combined with thrombocytopenia After enrollment liver disease treatment was supplemented with avatripopal for 5 days The baseline demographic data and biochemical data of the subjects were collected Biochemical indexes of avatripopal were monitored during treatment and after withdrawal The proportion of patients with platelet count 50109L on the day of selective invasive and minimally invasive surgery was analyzed The incidence of adverse events was observed To investigate the efficacy and safety of avatripopal in chronic liver disease patients with thrombocytopenia undergoing elective invasive and minimally invasive surgery To provide reference for related clinical treatment
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None